An intravenous infusion of scopolamine induced significant depression improvement in three to five days. The effect persisted for at least two weeks after three doses.
The hunt for a fast-acting antidepressant moved a step forward with a report of the efficacy of scopolamine, a drug commonly used to treat vertigo, in a clinical trial.
A muscarinic cholinergic receptor antagonist, scopolamine is commonly available in a type of transdermal patch indicated for treating motion sickness. The patch delivers up to one milligram of scopolamine over three days.
Vertigo Drug Shows Promise as Depression Treatment
Комментариев нет:
Отправить комментарий